|Thursday, June 15, 2023|
WELCOME & OPENING REMARKS
KEYNOTE SESSION 1: The vision
of the Biotechnology & Life Sciences sector: Opportunities & challenges
|12:35-14:30||NETWORKING LUNCH - EXHIBITION BOOTH PRESENTATIONS - B2B MEETINGS|
KEYNOTE SESSION 2: Bridging the Gap from Research to
Chairperson: Georges Kotrotsios, Technology Advisor Roumai Medical; Member, Industrial Advisory Board, Swiss Academy of Engineering Sciences, Switzerland
|17:30-19:00||NETWORKING DRINKS - EXHIBITION BOOTH PRESENTATIONS - B2B MEETINGS|
|Friday, June 16, 2023|
INNOVATION: Your changing world with the new EU Pharma Legislation
EU pharma legislation is going to change your business. What you make, where and how you sell it, and whether your business model is even viable.
The European Commission published new legislative proposals in April that will redefine the business model of biotechnology in Europe. In trying to bring medicines to more patients, the legislation proposals reduce data protection, limit exclusivity for orphan medicines and brings heavy pressure to launch in all 27 Member States within two years of EMA approval.
Changing the rule book that has helped build Europe’s small company ecosystem over the last 20 years is going to have consequences for start-ups, those seeking scale up investment, clinical trials and companies going to market, often for the first time.
This session/panel, chaired by EuropaBio, presents the key impacts points for biotechnology innovation within Greece, with contributions from small and large companies and policy makers – bring your voice to the discussion for the future of your own science.
Chairperson: Claire Skentelbery, Director General EuropaBio, Belgium
KEYNOTE SESSION 3: The role of clinical research in
supporting disruptive innovation
Chairperson: Nassos Alevizopoulos, Senior Scientific Advisor, Pharmassist Ltd, Greece
|12:00-14:00||NETWORKING LUNCH - EXHIBITION BOOTH PRESENTATIONS - B2B MEETINGS|
KEYNOTE SESSION 4: Investment
Opportunities for Disruptive Innovation
Chairperson: Elias Papatheodorou, Board Chair, HepaRegeniX (Germany) & Memo Therapeutics (Switzerland); Board member, Tribune Therapeutics, Sweden
|16:30-18:30||EXHIBITION BOOTH PRESENTATIONS & B2B MEETINGS|
|Saturday, June 17, 2023|
Precision Medicine - Innovative Approaches to Tailoring Disease, Prevention & Treatment
Chairperson: Stamatiki Kritas, Business Development Manager HBio
|11:30-12:00||NETWORKING MORNING TEA / EXHIBITION BOOTH PRESENTATIONS / B2B MEETINGS|
|12:00-14:00||INTERACTIVE WORKSHOP FOR STARTUPS & SMEs|
|12:00-12:50||Digital Transformation in the Healthcare Sector: How High Performance Computing can transform your Business.
The performance of almost all industries is significantly impacted by digital transformation, and healthcare is no exception. Especially for the healthcare and biotech sector is crucial to offer better patient care digitally, wherever the patient may be. There are a growing number of opportunities in the diagnostics and healthcare sectors related to digital transformation offering enormous opportunities for the innovative start-up companies. The European Digital Innovation Hubs (EDIHs), a pan-European Initiative, are one-stop shops that assist businesses and the public sector in responding to digital challenges and enhancing their competitiveness.
Dimitrios Filippidis, Senior Project Manager at the ICS-FORTH, will present the European Digital Innovation Hub on Precision Medicine and Innovative E-health Services (smartHEALTH) that brings together all the research and innovation leaders in Greece in the field of digital and smart health to facilitate the digital transformation of the private and public sector.
Eleni Kanellou, Research Collaborator at ICS-FORTH, will demonstrate the importance of adapting High Performance Computing (HPC) in SMEs and its impact to drug discovery, personalized medicine and healthcare.
Participants will have the opportunity to get an overview of the various benefits that HPC can bring to their business through the smartHEALTH Digital Innovation Hub.
|12:50-13:20||Preparing for investment in changing landscape of capital
Christian Kumar, Entrepreneur in Residence; Research, Enterprise & Scholarship Department, The Open University, UK
|13.20-13.30||Challenges during the establishment of a startup
Barbara Geladakis, Founder & CEO, Rodi Fertility
|13.30-14.00||Discussion & Q&A|
|14:00-15:00||NETWORKING LUNCH / EXHIBITION BOOTH PRESENTATIONS / B2B MEETINGS|
|15:00-17:00||PITCH YOUR IDEA
Moderator: Michael Dritsas, CEO, Elevate Greece SA
|17:00-18:00||FINAL REMARKS - ANNOUNCEMENT OF WINNERS|